Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial

Targeting very early systemic sclerosis: a case-based review

(2019) Konstantinos Melissaropoulos et al.   RHEUMATOLOGY INTERNATIONAL

Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects

(2018) Sahajal Dhooria et al.   PLoS One

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience

(2017) Misbah Baqir et al.   PLoS One

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

(2016) D. Khanna et al.   JOURNAL OF RHEUMATOLOGY

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

(2016) Martin Kolb et al.   THORAX

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?

(2015) Michele Iudici et al.   AUTOIMMUNITY REVIEWS

Early systemic sclerosis—opportunities for treatment

(2015) Lazaros I. Sakkas et al.   CLINICAL RHEUMATOLOGY

Safety and Effectiveness of Mycophenolate in Systemic Sclerosis. A Systematic Review

(2015) Mohammed A. Omair et al.   PLoS One

Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case–control study

(2014) P. T. Chan et al.   CLINICAL RHEUMATOLOGY

Mortality and survival in systemic sclerosis: Systematic review and meta-analysis

(2014) Manuel Rubio-Rivas et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

A Prospective Observational Study of Mycophenolate Mofetil Treatment in Progressive Diffuse Cutaneous Systemic Sclerosis of Recent Onset

(2012) F. A. MENDOZA et al.   JOURNAL OF RHEUMATOLOGY

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

(2011) E. N. Le et al.   ANNALS OF THE RHEUMATIC DISEASES

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study

(2009) D. Khanna et al.   RHEUMATOLOGY

Effect of Mycophenolate Mofetil on Pulmonary Function in Scleroderma-Associated Interstitial Lung Disease

(2007) Anthony J. Gerbino et al.   CHEST

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

(2007) Ana C. Zamora et al.   RESPIRATORY MEDICINE